Measuring Acute Drug Demand in Humans

NCT05829655 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

SUSPENDED

Status

75

Enrollment

OTHER

Sponsor class

Stopped The trial is currently paused during a move to a new institution and acquisition of the new IRB approval at University of Maryland, Baltimore

Conditions

Opioid Use Disorder
Opioid Dependence

Interventions

DRUG: Drug A (Blinded Drug)
DRUG: Drug B (Blinded Drug)
DRUG: Drug C (Blinded Drug)
DRUG: Drug D (Blinded Drug)
DRUG: Suvorexant (20mg/day)
DRUG: Placebo

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]